Header Logo

Connection

LEIDY CARABALLO GALVA to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications LEIDY CARABALLO GALVA has written about Antibodies, Monoclonal.
LEIDY CARABALLO GALVA
Connection Strength
0.125
Antibodies, Monoclonal
  1. Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Hepatology. 2022 08; 76(2):330-344.
    View in: PubMed
    Score: 0.125
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.